Answer
Pancreatitis is reported as common, occurring in at least 1 in 100 but fewer than 1 in 10 patients receiving mercaptopurine for the unlicensed indication of inflammatory bowel disease.
Sources for this answer
- Xaluprine 20 mg/ml oral suspensionNova Laboratories Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked